Secondary Logo

Published Ahead-of-Print - Last Updated: November 14, 2018

The editors of this journal are pleased to offer electronic publication of accepted papers prior to print publication. These papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue.

Disclaimer: Articles appearing in this Published Ahead-of-Print section have been peer-reviewed and accepted for publication in this journal and posted online before print publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Lippincott Williams & Wilkins, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained in the articles in this section.

Published Ahead-of-Print Articles are available in PDF format only.

PDF Only

Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases

Drago, Joshua Z.; Lawrence, Donald; Livingstone, Elisabeth; More

Melanoma Research. ., Post Author Corrections: October 29, 2018

A meta-analysis of melanoma risk in industrial workers

Vujic, Igor; Gandini, Sara; Stanganelli, Ignazio; More

Melanoma Research. ., Post Author Corrections: October 26, 2018

Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive

Ghate, Sameer; Ionescu-Ittu, Raluca; Burne, Rebecca; More

Melanoma Research. ., Post Author Corrections: October 09, 2018

Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients

Tan, Sally Y.; Najita, Julie; Li, Xiaoxue; More

Melanoma Research. ., Post Author Corrections: August 30, 2018

PDF Only

Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitors refractory advanced melanoma

Seremet, Teofila; Planken, Simon; Schwarze, Julia K.; More

Melanoma Research. ., Post Author Corrections: September 11, 2018

PDF Only